Dubai Investments sold its 66 per cent stake in pharmaceutical company Globalpharma for Dh385 million in the second quarter. Above, the Globalpharma plant in the UAE. Courtesy Globalpharma
Dubai Investments sold its 66 per cent stake in pharmaceutical company Globalpharma for Dh385 million in the second quarter. Above, the Globalpharma plant in the UAE. Courtesy Globalpharma

Dubai Investments posts 17% rise in third-quarter profit



Dubai Investments (DI) said third-quarter profit rose 17 per cent to Dh189 million as rental income grew.

Nine-month net income advanced 87 per cent to Dh995m compared to the same period a year earlier, the company said in a stock exchange filing.

The investment company’s total revenues rose to Dh2.4 billion from Dh1.9bn, while its total assets on September 30 stood at Dh14.25bn after the sale of a 66 per cent stake in the pharmaceutical company Globalpharma for Dh385m to France’s Sanofi in the second quarter.

“We are witnessing optimistic sentiments across various sectors of the economy, which places us in a good position to capitalise on the available opportunities in line with our growth strategy,” said Khalid bin Kalban, the managing director and chief executive of Dubai Investments. “DI has ramped up its liquidity following strong operating results, and this will enable us to take advantage of opportunities in the market.”

DI owns about 35 subsidiaries and joint ventures in a variety of sectors including manufacturing, property development and information technology. Strong demand for commercial and industrial space in the emirate has helped drive returns from its business park unit while rebounding construction industry demand has also helped its building materials and glass making operations.

The company’s investments in the UAE almost doubled to Dh854m in the nine months to September, while in other GCC countries it jumped to Dh402m from Dh272m. DI’s investments in other countries increased the most to Dh875m from Dh330m, a growth of 165 per cent.

The firm expects its credit rating to be increased to BBB by the end of the year. Its Dubai Investments Park Development Company unit, which raised US$300m from an Islamic bond in February, holds a BB+ grade from Standard & Poor’s.

thamid@thenational.ae

Follow The National's Business section on Twitter

BIOSAFETY LABS SECURITY LEVELS

Biosafety Level 1

The lowest safety level. These labs work with viruses that are minimal risk to humans.

Hand washing is required on entry and exit and potentially infectious material decontaminated with bleach before thrown away.

Must have a lock. Access limited. Lab does not need to be isolated from other buildings.

Used as teaching spaces.

Study microorganisms such as Staphylococcus which causes food poisoning.

Biosafety Level 2

These labs deal with pathogens that can be harmful to people and the environment such as Hepatitis, HIV and salmonella.

Working in Level 2 requires special training in handling pathogenic agents.

Extra safety and security precautions are taken in addition to those at Level 1

Biosafety Level 3

These labs contain material that can be lethal if inhaled. This includes SARS coronavirus, MERS, and yellow fever.

Significant extra precautions are taken with staff given specific immunisations when dealing with certain diseases.

Infectious material is examined in a biological safety cabinet.

Personnel must wear protective gowns that must be discarded or decontaminated after use.

Strict safety and handling procedures are in place. There must be double entrances to the building and they must contain self-closing doors to reduce risk of pathogen aerosols escaping.

Windows must be sealed. Air from must be filtered before it can be recirculated.

Biosafety Level 4

The highest level for biosafety precautions. Scientist work with highly dangerous diseases that have no vaccine or cure.

All material must be decontaminated.

Personnel must wear a positive pressure suit for protection. On leaving the lab this must pass through decontamination shower before they have a personal shower.

Entry is severely restricted to trained and authorised personnel. All entries are recorded.

Entrance must be via airlocks.

COMPANY PROFILE
Name: Airev
Started: September 2023
Founder: Muhammad Khalid
Based: Abu Dhabi
Sector: Generative AI
Initial investment: Undisclosed
Investment stage: Series A
Investors: Core42
Current number of staff: 47
 
Porsche Macan T: The Specs

Engine: 2.0-litre 4-cyl turbo 

Power: 265hp from 5,000-6,500rpm 

Torque: 400Nm from 1,800-4,500rpm 

Transmission: 7-speed dual-clutch auto 

Speed: 0-100kph in 6.2sec 

Top speed: 232kph 

Fuel consumption: 10.7L/100km 

On sale: May or June 

Price: From Dh259,900